Synergy and competition between cancer genome sequencing and epigenome mapping projects

Genome Medicine

Volumn 6, Issue 5, 2014, Pages

  Bock, Christoph ^a,b,c  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ARTICLE; CANCER PATIENT; CANCER THERAPY; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CLONAL EVOLUTION; COMPETITION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE MAPPING; GENE MUTATION; GENE REPRESSION; GENE SEQUENCE; GENETIC DISORDER; HEMATOPOIETIC SYSTEM; HISTONE MODIFICATION; HUMAN; HUMAN GENOME PROJECT; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REGULATOR GENE; TUMOR GENE;

EID: 84901684559     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm557     Document Type: Article

References (10)

1. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004, 4:177-183. 10.1038/nrc1299, 2665285, 14993899.
2. Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med 2011, 17:297-303. 10.1038/nm.2323, 21383744.
3. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES, Getz G. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014, 505:495-501. 10.1038/nature12912, 24390350.
4. Pujadas E, Feinberg AP. Regulated noise in the epigenetic landscape of development and disease. Cell 2012, 148:1123-1131. 10.1016/j.cell.2012.02.045, 3488344, 22424224.
5. Jones PA, Martienssen R. A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 2005, 65:11241-11246. 10.1158/0008-5472.CAN-05-3865, 16357125.
6. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004, 4:143-153. 10.1038/nrc1279, 14732866.
7. Garraway LA, Lander ES. Lessons from the cancer genome. Cell 2013, 153:17-37. 10.1016/j.cell.2013.03.002, 23540688.
8. Beck S, Bernstein BE, Campbell RM, Costello JF, Dhanak D, Ecker JR, Greally JM, Issa JP, Laird PW, Polyak K, Tycko B. Jones PA; AACR Cancer Epigenome Task Force: A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task Force. Cancer Res 2012, 72:6319-6324. 10.1158/0008-5472.CAN-12-3658, 23188507.
9. Huang S. On the intrinsic inevitability of cancer: from foetal to fatal attraction. Semin Cancer Biol 2011, 21:183-199. 10.1016/j.semcancer.2011.05.003, 21640825.
10. Bock C, Lengauer T. Managing drug resistance in cancer: lessons from HIV therapy. Nat Rev Cancer 2012, 12:494-501. 10.1038/nrc3297, 22673150.